Marengo Therapeutics
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$119M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Marengo Therapeutics is a biotechnology company that develops precision immunotherapies for cancer and autoimmune diseases through its proprietary T-cell activation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marengo Therapeutics Comparables
Compare Marengo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Normunity | 84% | |
| Repertoire Immune Medicines | 82% | |
| Crossbow Therapeutics | 78% | |
Marengo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A | Jan 3, 2018 |
Key People
Founding team and executive leadership
Marengo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Unveiled partnered STAR program IPN01203/STAR0501, now in Phase 1 trials.
- Apr 17, 2026
Initial Phase 2 results for invikafusp alfa in combination with TRODELVY reported at AACR 2026.
Marengo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Marengo Therapeutics's valuation, stock price, and market status.